MiR‐198 had already been confirmed to have suppression on tumor cells by targeting serine hydroxymethyltransferase 1 (SHMT1).24 However, in our study the proto‐oncogene MYC was the target rather than an enzyme gene, thus providing a new perspective on miR‐198‐related cancer inhibition. This evidence concerns the gene SHMT1 and neoplasm.